PA
Parizad Adil Elchidana
About Parizad Adil Elchidana
Data last updated:
Parizad Adil Elchidana is an Additional Director at Iqgen-X Pharma Private Limited (since 2021). The companies operate in Pharma. Iqgen-X Pharma Private Limited reported revenue of ₹8.51 Cr (FY 2023). Earlier, Parizad Adil Elchidana was a Director at Apotex Research Private Limited (2004–2017) and Director at Apotex Pharmachem India Private Limited (2014–2016).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Iqgen-X Pharma Private Limited U74999MH2016PTC286716 | Additional Director | 30 Sep 2021 | 2016 | ₹8.51 Cr (FY 2023) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Apotex Research Private Limited U73100KA2003PTC032103 | Director | 10 Jun 2004 | 2003 | ₹727 Cr (FY 2025) | Active |
 Apotex Pharmachem India Private Limited U24231KA2003PTC032104 | Director | 01 Jun 2014 | 2003 | ₹142 Cr (FY 2024) | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Parizad Adil Elchidana
| Name | DIN | Company | Designation |
|---|---|---|---|
| Madhu Hariharan | 06384549 | Iqgen-X Pharma Private Limited | Director |
| Mandar Madhukar Kodgule | 07734636 | Iqgen-X Pharma Private Limited | Director |
| Yatendra Kumar | 07698827 | Iqgen-X Pharma Private Limited | Director |
| Yogita Mandar Kodgule | 07812969 | Iqgen-X Pharma Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Parizad Adil Elchidana
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Parizad Adil Elchidana
Parizad Adil Elchidana currently holds 1 directorship: Iqgen-X Pharma Private Limited (Additional Director, since 30 Sep 2021, revenue ₹8.51 Cr (FY 2023)).
Parizad Adil Elchidana was first appointed on 10 Jun 2004 as Director at Apotex Research Private Limited. The most recent appointment on record is 30 Sep 2021 at Iqgen-X Pharma Private Limited.
Parizad Adil Elchidana held 2 earlier board appointments: Apotex Research Private Limited (Director, 10 Jun 2004 to 12 Jan 2017); Apotex Pharmachem India Private Limited (Director, 01 Jun 2014 to 01 Feb 2016).
The current boards of Parizad Adil Elchidana's companies include Madhu Hariharan (Iqgen-X Pharma Private Limited), Mandar Madhukar Kodgule (Iqgen-X Pharma Private Limited), Yatendra Kumar (Iqgen-X Pharma Private Limited), Yogita Mandar Kodgule (Iqgen-X Pharma Private Limited).